Joseph G. Cory

5.0k total citations · 1 hit paper
129 papers, 4.2k citations indexed

About

Joseph G. Cory is a scholar working on Molecular Biology, Oncology and Inorganic Chemistry. According to data from OpenAlex, Joseph G. Cory has authored 129 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 50 papers in Oncology and 36 papers in Inorganic Chemistry. Recurrent topics in Joseph G. Cory's work include Metal-Catalyzed Oxygenation Mechanisms (36 papers), Biochemical and Molecular Research (35 papers) and Metal complexes synthesis and properties (24 papers). Joseph G. Cory is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (36 papers), Biochemical and Molecular Research (35 papers) and Metal complexes synthesis and properties (24 papers). Joseph G. Cory collaborates with scholars based in United States, Netherlands and Canada. Joseph G. Cory's co-authors include Ann H. Cory, Terence C. Owen, J. A. Barltrop, Alan C. Sartorelli, Robert J. Suhadolnik, Gisbert Weckbecker, Atsushi Sato, Rick A. Finch, Earl Frieden and Germana Rappa and has published in prestigious journals such as Nature, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joseph G. Cory

129 papers receiving 4.0k citations

Hit Papers

Use of an Aqueous Soluble Tetrazolium/Formazan Assay for ... 1991 2026 2002 2014 1991 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture
    1991 1.3k citations Ann H. Cory, Joseph G. Cory et al. PubMed profile →

Peers

Joseph G. Cory
Frank Rusnak United States
John de Jersey Australia
Anne‐Marie Lambeir Belgium
Scott A. Raybuck United States
K.L. Kavanagh United Kingdom
Dante Neculai China
Michael V. Berridge New Zealand
Vladimı́r Kryštof Czechia
Ann H. Cory United States
Eranthie Weerapana United States
Frank Rusnak United States
Joseph G. Cory
Citations per year, relative to Joseph G. Cory Joseph G. Cory (= 1×) peers Frank Rusnak

Countries citing papers authored by Joseph G. Cory

Since Specialization
Citations

This map shows the geographic impact of Joseph G. Cory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph G. Cory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph G. Cory more than expected).

Fields of papers citing papers by Joseph G. Cory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph G. Cory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph G. Cory. The network helps show where Joseph G. Cory may publish in the future.

Co-authorship network of co-authors of Joseph G. Cory

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph G. Cory. A scholar is included among the top collaborators of Joseph G. Cory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph G. Cory. Joseph G. Cory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Z. Ping, Yashang Lee, Michael F. Belcourt, et al.. (2011). Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage. Molecular Pharmacology. 80(6). 1000–1012. 15 indexed citations
2.
Dinkova‐Kostova, Albena T., Ann H. Cory, Richard E. Bozak, Ronald J. Hicks, & Joseph G. Cory. (2006). Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway. Cancer Letters. 245(1-2). 341–349. 19 indexed citations
3.
Lin, Z. Ping, Michael F. Belcourt, Rocco Carbone, et al.. (2006). Excess ribonucleotide reductase R2 subunits coordinate the S phase checkpoint to facilitate DNA damage repair and recovery from replication stress. Biochemical Pharmacology. 73(6). 760–772. 34 indexed citations
4.
Cory, Ann H. & Joseph G. Cory. (2005). Induction of apoptosis in p53-deficient L1210 cells by an I-κ-B-α-inhibitor (Bay 11-7085) via a NF-κ-B-independent mechanism. Advances in Enzyme Regulation. 45(1). 85–93. 3 indexed citations
5.
Lin, Z. Ping, Michael F. Belcourt, Joseph G. Cory, & Alan C. Sartorelli. (2004). Stable Suppression of the R2 Subunit of Ribonucleotide Reductase by R2-targeted Short Interference RNA Sensitizes p53(–/–) HCT-116 Colon Cancer Cells to DNA-damaging Agents and Ribonucleotide Reductase Inhibitors. Journal of Biological Chemistry. 279(26). 27030–27038. 69 indexed citations
6.
Cory, Ann H. & Joseph G. Cory. (2004). Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53. Advances in Enzyme Regulation. 44(1). 11–25. 3 indexed citations
7.
Sibert, John W., Ann H. Cory, & Joseph G. Cory. (2002). Lipophilic derivatives of cyclam as new inhibitors of tumor cell growth. Chemical Communications. 154–155. 53 indexed citations
8.
9.
He, Aiwu Ruth & Joseph G. Cory. (1998). Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.. PubMed. 10(9). 455–64. 11 indexed citations
10.
Cory, Joseph G., Ann H. Cory, Germana Rappa, et al.. (1995). Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo. Advances in Enzyme Regulation. 35. 55–68. 33 indexed citations
11.
Cory, Ann H., Vicente Sámano, Morris J. Robins, & Joseph G. Cory. (1994). 2′-deoxy-2′-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture. Biochemical Pharmacology. 47(2). 365–371. 17 indexed citations
12.
Cory, Ann H. & Joseph G. Cory. (1994). Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs. Advances in Enzyme Regulation. 34. 1–12. 1 indexed citations
13.
Cory, Joseph G., et al.. (1993). Structural aspects of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity. Advances in Enzyme Regulation. 33. 129–140. 5 indexed citations
14.
15.
16.
Tihan, Tarık, et al.. (1990). Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture. Cancer Chemotherapy and Pharmacology. 26(5). 323–329. 10 indexed citations
17.
Cory, Joseph G., et al.. (1989). Mechanisms of Drug Resistance to Inhibitors Directed at the Individual Subunits of Ribonucleotide Reductase. PubMed. 1(1). 13–20. 10 indexed citations
18.
Weckbecker, Gisbert, Eric J. Lien, & Joseph G. Cory. (1988). Properties of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of mammalian ribonucleotide reductase. Biochemical Pharmacology. 37(3). 529–534. 14 indexed citations
19.
Weckbecker, Gisbert, et al.. (1987). Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.. PubMed. 47(3). 18–20. 10 indexed citations
20.
Cory, Joseph G. & Peter Chiba. (1985). Combination chemotherapy directed at the components of nucleoside diphosphate reductase. Pharmacology & Therapeutics. 29(1). 111–127. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Rusnak Breakdown of academic impact, for papers by John de Jersey Breakdown of academic impact, for papers by Anne‐Marie Lambeir Breakdown of academic impact, for papers by Scott A. Raybuck Breakdown of academic impact, for papers by K.L. Kavanagh Breakdown of academic impact, for papers by Dante Neculai Breakdown of academic impact, for papers by Michael V. Berridge Breakdown of academic impact, for papers by Vladimı́r Kryštof Breakdown of academic impact, for papers by Ann H. Cory Breakdown of academic impact, for papers by Eranthie Weerapana
Rankless by CCL
2026